4-Acetyl-2-methylbenzoic acid is a high-purity aromatic carboxylic acid derivative, appearing as a white to yellowish crystalline powder, primarily utilized as a versatile organic synthesis building block and a critical pharmaceutical intermediate for advanced chemical manufacturing. Characterized by the presence of both a reactive carboxyl group and an acetyl ketone moiety on a methyl-substituted benzene ring, this compound offers excellent solubility in polar organic solvents such as DMSO, DMF, ethanol, and dichloromethane, while remaining stable under standard storage conditions. It is specifically designed for research scientists, API manufacturers, and agrochemical developers who require a reliable, high-quality precursor to construct complex molecular architectures, including active pharmaceutical ingredients (APIs) and high-performance functional materials.
Tilmicosin is a macrolide antibiotic specifically developed for veterinary use, renowned for its exceptional efficacy against respiratory pathogens such as Mycoplasma and Gram-positive bacteria in livestock. It features a unique pharmacokinetic profile that allows for extensive tissue penetration and a long-lasting half-life, making it an ideal choice for the prevention and control of bovine and porcine respiratory diseases. This high-purity powder is designed for easy formulation into feed or water, providing reliable and sustained therapeutic levels to improve animal health and productivity in large-scale farming operations.
7-Acetyltaxol is a semi-synthetic derivative of paclitaxel, characterized as a white to off-white solid powder primarily utilized as a high-purity reference standard, impurity profiling marker (often identified as Paclitaxel EP Impurity L), and a vital tool for early-stage pharmacological research in oncology. This stable taxane analog features an acetyl group modification at the C-7 position, making it indispensable for researchers conducting structure-activity relationship (SAR) studies, analytical method validation, and the qualitative analysis of paclitaxel-based drug substances. It is specifically catered to pharmaceutical R&D scientists, quality control laboratories, and academic institutions requiring reliable chemical references to ensure drug safety, purity, and compliance with international pharmacopeial standards.
GS-441524 is a nucleoside analog and the active metabolite of Remdesivir (GS-5734), developed by Gilead Sciences as a broad-spectrum antiviral agent. It is widely recognized as a highly effective treatment for Feline Infectious Peritonitis (FIP), a once-fatal coronavirus disease in cats, and serves as a key pharmaceutical intermediate for antiviral research. The product is typically supplied as a high-purity white to off-white powder for research and development purposes in both medical and veterinary fields.
AST2818 mesylate, also known as Alflutinib or Furmonertinib, is a highly selective third-generation EGFR tyrosine kinase inhibitor (TKI) developed for the targeted treatment of non-small cell lung cancer (NSCLC). It is specifically engineered to potently inhibit EGFR sensitizing mutations (such as exon 19 deletions and L858R) as well as the resistant T790M mutation, while exhibiting minimal off-target effects on wild-type EGFR, thereby offering a favorable safety profile for patients with advanced or metastatic disease.
Ceforanide (CAS 60925-61-3) is a high-purity, second-generation cephalosporin antibiotic provided as a reference standard. It is characterized as a parenteral, long-acting cephalosporin with a broad spectrum of activity against Gram-positive and Gram-negative bacteria. Its chemical structure includes an aminothiazolyl moiety and a tetrazole ring, contributing to its enhanced stability against certain β-lactamases. Historically used clinically, it is now primarily utilized in pharmaceutical research as a model compound and a critical standard for quality control.
Cariprazine (CAS 839712-12-8) is a high-purity, atypical antipsychotic compound supplied as a reference standard. It is a piperazine derivative functioning as a dopamine D3 and D2 receptor partial agonist with preferential binding affinity for the D3 receptor. Approved by the FDA and EMA, it is clinically indicated for the treatment of schizophrenia, manic or mixed episodes associated with bipolar I disorder, and as an adjunctive therapy for major depressive disorder (MDD), representing a cornerstone in modern neuropsychiatric therapeutics.
Clematichinenoside AR (CAS 761425-93-8) is a high-purity, triterpenoid saponin primarily isolated from the traditional Chinese medicinal herb Clematis chinensis. It serves as a principal bioactive marker compound for this plant. Recognized for its potent anti-inflammatory, analgesic, and immunomodulatory activities, it is extensively researched for its therapeutic potential in managing rheumatoid arthritis, osteoarthritis, and other inflammatory disorders, positioning it as a key compound in both phytochemical research and drug discovery.
Alantolactone (CAS 546-43-0), also known as (+)-Alantolactone or Inula camphor, is a high-purity natural sesquiterpene lactone primarily isolated from Inula helenium(Elecampane) and other Asteraceae plants. It is a key bioactive compound characterized by its distinctive α-methylene-γ-lactone moiety, which is responsible for its potent electrophilic reactivity. Widely used in traditional medicine for its antimicrobial and anti-inflammatory properties, Alantolactone is now a prominent research tool in oncology and immunology due to its ability to selectively inhibit STAT3 signaling and induce apoptosis in cancer cells.
Pinocembrin (5,7-dihydroxyflavanone, CAS 480-39-7) is a high-purity natural flavanone predominantly found in propolis, honey, and various medicinal plants like Pinusand Eucalyptus. It is a key bioactive flavonoid recognized for its broad-spectrum pharmacological profile, including potent antioxidant, anti-inflammatory, and neuroprotective activities. Structurally characterized as a dihydroflavonoid, it serves as a critical intermediate in flavonoid biosynthesis and is widely utilized in nutraceutical, cosmetic, and pharmaceutical research as a reference standard and active ingredient
Beta-D-Fructose 6-phosphate (β-D-F6P, CAS 26177-86-6) is a high-purity biochemical reagent supplied as a stable disodium salt. It is a central intermediate metabolite in the glycolytic pathway, positioned between Glucose-6-phosphate and Fructose-1,6-bisphosphate. This compound is essential for research in energy metabolism, enzyme kinetics, and metabolic flux analysis, serving as a critical substrate for phosphofructokinase (PFK) and other regulatory enzymes.
